Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
HI-CHEW® Returns to Fortnite With Limited-Time Games, Collectibles and New Mascot, Chewbie
-
Vital Farms Reimagines the Iconic Gingerbread House; Releases Limited-Edition Holiday ‘Gingerbread Farmhouse Kit’ in Partnership with Supernatural and King Arther Baking Company
-
Finacity Facilitates an up to USD 50 Million Lender Finance Programme for Volo Fin Pte Ltd
-
87% OF CONSUMERS PLAN TO CELEBRATE THANKSGIVING; 31% PLAN TO PURCHASE ALCOHOLIC BEVERAGES, NUMERATOR REPORTS
-
Hashdex Nasdaq Crypto Index Europe ETP Surpasses $500 Million
-
Changelly Introduces Black Friday Campaign with Crypto Deals and Prize Pool
-
Wreaths Across America Announces the Mobile Education Exhibit 2025 National Tour Schedule
-
Chuck E. Cheese Enters New Era of Active Play with Launch of Adventure Zones
-
ParaZero Received Regulatory Approval in Europe for its Drone Safety System
-
Dogwood Therapeutics, Inc. Announces Low Dose IMC-2 Treatment Reduces Long-COVID Related Fatigue and Sleep Disturbance in an Investigator-Initiated Study
-
Pineapple Energy Announces Corporate Name Change to SUNation Energy, Inc., and New Ticker Symbol
-
New Consumer Report Reveals Millennials Account for Largest Share of Pre-Roll Purchases
-
AITX’s RAD to Announce Potentially Revolutionary AI-Based Security Innovation
-
Silo Pharma Announces Positive Results for Novel SPC-15 Treatment Targeting Stress-Related Disorders
-
SHAREHOLDER ALERT: Berger Montague Reminds Acadia Healthcare Company (NASDAQ: ACHC) Investors of Class Action Lawsuit Deadline
-
American Rare Earths Engages BMO Capital Markets as Financial Adviser
-
Phunware to Participate in the 13th Annual ROTH Technology Conference in New York City November 20, 2024
-
Hanmi Bank Opens Korea Representative Office in Seoul’s International Finance Center
-
How $ATO Is Gaining Traction in the Memecoin Market and Drawing Parallels to $DOGE
-
Artelo Biosciences to Present Key Data on Three Development Programs at the 7th Cannabinoid Drug Development Summit
-
AmpliTech Group's AmpliTech Inc. Division Secures Initial Purchase Order Under 5-Year Basic Order Agreement With Fortune 1000 U.S. Company
-
Brad Edgar Joins Stifel as Managing Director and Lead Healthcare Equity Trader
-
Cerevance Doses First Patient in Pivotal Phase 3 ARISE Trial of Solengepras for Treatment of Parkinson’s Disease
-
Ocean Power Technologies to Release Fiscal 2025 Second Quarter Early Earnings on December 2, 2024
-
Treasure Global Inc. Reports First Quarter Fiscal Year 2025 Financial Results
-
CleanCore Solutions, Inc. (ZONE) Launches Pilot Program with International Hotel Chain
-
Jet.AI to Regain Compliance with Nasdaq Stockholders’ Equity Requirement
-
FOXO TECHNOLOGIES INC.’S BOARD OF DIRECTORS ANNOUNCES SPECIAL MEETING OF SHAREHOLDERS
-
Draganfly Announces Pricing of US$3.76 Million Registered Direct Offering
-
Complete Solar’s Blue Raven Signs Installation Agreement with Sunder Energy
-
Nuvini (Nasdaq: NVNI) Announces Aaron Ross as Board Adviser
-
gkv informatik Selects Rezolve Ai’s Brain Suite to Drive Productivity and Innovation in the Healthcare Sector
-
Celularity Inc. Announces Resolution of Nasdaq Listing Compliance Matter
-
Vaccinex Reports Third Quarter 2024 Financial Results and Provides Corporate Update
-
Cassava Sciences Appoints Freda Nassif as Chief Commercial Officer
-
Foremost Clean Energy Announces Strategic Engagement with Red Cloud Financial Services
-
ECD Auto Design Announces Addition of Chief Revenue Officer Kevin Kastner
-
Allogene Therapeutics Presents Preclinical Data for ALLO-329, an Allogeneic CD19/CD70 Dual CAR T for the Treatment of Autoimmune Disease at the American College of Rheumatology (ACR) Convergence
-
CSW Industrials Updates Share Repurchase Program
-
Dario Pressimone Joins Edible Garden as Vice President of Digital and E-Commerce
-
Day One to Participate in the Piper Sandler 36th Annual Healthcare Conference
-
Corporate and Municipal CUSIP Request Volumes Surge in October
-
Newtek Bank, N.A. Launches Newtek Zero-Fee Business Banking™
-
The subscription period for warrants of series TO8 B starts today and three large shareholders as well as the Board and management intend to exercise warrants corresponding to approximately 31 percent
-
Form 8.3 - TT Electronics plc
-
MAJOR SHAREHOLDER ANNOUNCEMENT
-
Nano Dimension Reminds Shareholders that Time Is Running Out to Protect Their Investment - Vote FOR Nano’s Proposals
-
iRhythm Data Presented at the American Heart Association 2024 Scientific Sessions Reinforce Clinical and Health Economic Value of Zio Long-Term Continuous Monitoring
-
Private Sector Buyers Drive Sustainable Aviation Fuel Growth Through Strategic Purchases
-
Canadian Helen Keller Centre to Begin Building 56 Units of Affordable, Accessible Housing in Toronto For People Who Are Deafblind


